BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25152439)

  • 1. Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway.
    Chen XQ; Liu X; Wang QX; Zhang MJ; Guo M; Liu F; Jiang WF; Zhou L
    Exp Cell Res; 2015 Jan; 330(1):43-55. PubMed ID: 25152439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIF promotes angiotensin II-induced cross-talk between fibroblasts and macrophages in atrial fibrosis.
    Chen XQ; Zhang DL; Zhang MJ; Guo M; Zhan YY; Liu F; Jiang WF; Zhou L; Zhao L; Wang QX; Liu X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):100-5. PubMed ID: 26056004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.
    Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease.
    Zhang D; Liu X; Chen X; Gu J; Li F; Zhang W; Zheng Y
    Cardiology; 2014; 129(4):216-23. PubMed ID: 25376239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
    Cao F; Li Z; Ding WM; Yan L; Zhao QY
    Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fus knockdown inhibits the profibrogenic effect of cardiac fibroblasts induced by angiotensin II through targeting Pax3 thereby regulating TGF-β1/Smad pathway.
    Wang G; Wu H; Liang P; He X; Liu D
    Bioengineered; 2021 Dec; 12(1):1415-1425. PubMed ID: 33896391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation.
    Zhang D; Chen X; Wang Q; Wu S; Zheng Y; Liu X
    PLoS One; 2017; 12(3):e0173759. PubMed ID: 28323847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A physiological concentration of glucocorticoid inhibits the pro-inflammatory cytokine-induced proliferation of adult rat cardiac fibroblasts: roles of extracellular signal-regulated kinase 1/2 and nuclear factor-κB.
    He YH; Zhang HN; Zhang GP; Hou N; Xiao Q; Huang Y; Wu JH; Luo MS; Zhang GS; Yi Q; Chen MS; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):739-46. PubMed ID: 21819443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
    Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone Alleviates Cardiac Fibrosis and Inhibits Endothelial to Mesenchymal Transition Induced by Pressure Overload.
    Wei WY; Zhang N; Li LL; Ma ZG; Xu M; Yuan YP; Deng W; Tang QZ
    Cell Physiol Biochem; 2018; 45(1):26-36. PubMed ID: 29310116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
    Shan H; Zhang Y; Lu Y; Zhang Y; Pan Z; Cai B; Wang N; Li X; Feng T; Hong Y; Yang B
    Cardiovasc Res; 2009 Aug; 83(3):465-72. PubMed ID: 19398468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
    Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of LPS-induced HIV type I activation in transgenic mouse macrophages.
    Kadoki M; Choi BI; Iwakura Y
    Int Immunol; 2010 Jun; 22(6):469-78. PubMed ID: 20504885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
    Shirai Y; Yoshiji H; Noguchi R; Kaji K; Aihara Y; Douhara A; Moriya K; Namisaki T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
    Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
    J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.